| |  | Larry Bock
male
(San Diego Area, ca, United States)
Larry Bock President and CEO Nanosys Inc Mr.Bock is the President and CEO of Nanosys, Inc. He is a General Partner of CW Group, where he focuses... |  | Bill Helman focuses on enterprise companies and technologies for Greylock, a private equity venture capital firm founded in 1965. Having joined... |  | Vicki L. Sato , Ph.D, is Professor of Management Practice at Harvard Business School, and also Professor of the Practice in the Department of... |  | Charles A. Sanders, M.D. Retired Chairman & CEO Glaxo, Inc. Charles A. Sanders , M.D., is the former chairman and CEO of Glaxo Inc., as well as... |  | David Armistead , Ph.D. Former Vice President and Site Head, Amgen Cambridge Research Center David Armistead has over 18 years of pharmaceutical... |  | Stuart Schreiber, Ph.D. Stuart Schreiber is the Morris Loeb Professor at Harvard University, where he is a member of the Department of Chemistry... |  | Nina Sawczuk , MS, MBA - Co-Founder and CEO Nina Sawczuk co-founded Zygogen in 1999. Sawczuk has a Masters in Molecular and Cellular Biology from... |  | Manuel A. Navia , Ph.D. Dr. Navia is currently an Executive-in-Residence at Oxford Bioscience Partners. He is also a consultant for a number of... |  | Joshua Boger Founder “I have always been fascinated by science; by how things work, and how things don’t work, and most importantly, by how I can... |  | Roger’s career spans over 20 years in venture-backed startup and major pharmaceutical companies, including Vertex Pharmaceuticals, Merck, Sharp & Do... | |
